Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 1/20 | 0.33 |
| ▸ | ECE1 | P42892 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.32 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.32 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.32 |
| ▸ | CMA1 | P23946 | 1/20 | 0.31 |
| ▸ | GLP1R | P43220 | 1/20 | 0.31 |
| ▸ | SCTR | P47872 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30817681 | 0.92 | GLP1R (0.32) | ADAMTS4ADAMTS5GLP1RSCTR | |
| SCHEMBL30817673 | 0.88 | — | — | |
| SCHEMBL30139578 | 0.88 | CMA1 (0.39) | CMA1 | |
| SCHEMBL30817667 | 0.86 | CTSK (0.31) | — | |
| SCHEMBL30817676 | 0.84 | GLP1R (0.31) | GLP1RSCTR | |
| SCHEMBL30195131 | 0.82 | PTPN1 (0.44) | — | |
| SCHEMBL29837202 | 0.82 | GLP1R (0.36) | FOLH1ADAMTS4ADAMTS5GLP1RSCTR | |
| SCHEMBL29908060 | 0.81 | ITGB3 (0.33) | — | |
| SCHEMBL28836215 | 0.81 | ITGB3 (0.33) | — | |
| SCHEMBL29871017 | 0.78 | NAALAD2 (0.36) | MMEECE1FOLH1DGAT1NAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117586375-B | Method for preparing semaglutin | 苏州金顶生物有限公司 | 2024-07-30 | — | — | CN | disclosed |
| CN-117586375-A | Method for preparing semaglutin | 苏州金顶生物有限公司 | 2024-02-23 | — | — | CN | disclosed |